Cargando…
COULD COVID-19 BE A HEMOGLOBINOPATHY?
The world is struggling to deal with the corona pandemic. Effective therapies are still awaited due to the lack of understanding of the pathophysiological mechanism of the disease. Bearing recent research and clinical observations in mind, the authors propose a novel physiological mechanism of COVID...
Autores principales: | Shakoori, Tania Ahmed, Hafeez, Muhammad Mansoor, Malik, Arif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253065/ https://www.ncbi.nlm.nih.gov/pubmed/34285445 http://dx.doi.org/10.20471/acc.2020.59.04.21 |
Ejemplares similares
-
Athrombocytopenic thrombotic microangiopathy, a condition that could be overlooked based on current diagnostic criteria
por: De Serres, Sacha A., et al.
Publicado: (2009) -
Could IGF-I levels play a neuroprotective role in patients with large vestibular schwannomas?
por: Fotakopoulos, George, et al.
Publicado: (2017) -
Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment
por: Londres, Henrry Diaz, et al.
Publicado: (2022) -
Patient satisfaction with telemedicine for prechemotherapy evaluation during the COVID-19 pandemic
por: Sathiyaraj, Ajithraj, et al.
Publicado: (2021) -
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy
por: Bersanelli, Melissa, et al.
Publicado: (2020)